Cannabidiol (CBD) - What we know and what we don't

Author/s: 
Grinspoon, Peter
Date Added: 
April 24, 2019
Journal/Publication: 
Harvard Health Blog
Publisher: 
Harvard University
Publication Date: 
August 24, 2018
Type: 
Patient Education Materials
Format: 
Web Page
Keywords 

RPR Commentary

This patient-friendly review of what we currently know about CBD includes a warning that CBD oil reduces the metabolism of warfarin and other drugs metabolized by the CYP450 enzyme system (the same system affected by grapefruit juice) causing elevation of the INR and increased risk of bleeding.   James W. Mold, MD, MPH

Abstract

Cannabidiol (CBD) has been recently covered in the media, and you may have even seen it as an add-in booster to your post-workout smoothie or morning coffee. What exactly is CBD? Why is it suddenly so popular?

Text Availability

Free full text